The joint association of lipoprotein(a) and Lp-PLA2 with the risk of stroke recurrence - Journal of Clinical Lipidology lipidjournal.com/article/S1933-… National Lipid Association

Atheroma microcalcification activity as quantified by 18F–NaF uptake (PET-CT) in individuals w/ subclinical atherosclerosis is significantly reduced after six months of high intensity statin therapy
🔗atherosclerosis-journal.com/article/S0021-…
João Borges Rosa Piotr Slomka PhD European Atherosclerosis Society #CvPrev

Nice article

Social Determinants of Cardiovascular Health

academic.oup.com/eurheartj/arti…

Great results, great drug, would love to have it in ROI, lucky NHS in England, still use of HIS not good enough and ezetimibe use very low

Semaglutide in Heart Failure
The worse the HF severity the more the benefit 🤔 independent of weight loss.
#HeartFailure2024

Thrilled to stand alongside a Prof Derek Connolly at the Cardio-Renal-Metabolic UK Cardio-renal-metabolic UK Summit in #Manchester tomorrow 🔬✨

🍭We’re gearing up to dive deep into T2DM guidelines. Exciting discussions ahead! #CardioMetabolicSummit #T2DMGuidelines AstraZeneca

Honored to share insights on stage with Prof Derek Connolly at #CVRMUK about enhancing access to cardio-renal protection in #T2DM .

🗼 #CardioTwitter Do you check HBA1c & uACR in your clinic? Do you initiate diabetic meds?

#CardioRenalMetabolic #HealthcareAccess #PatientCare

Lipoprotein (a) inhibition by small interfering RNA works amazingly

Thus is probably revolutionise coronary disease and aortic stenosis prevention

jamanetwork.com/journals/jama/…

Hyperlipidaemia in diabetes: are there particular considerations for next-generation therapies? link.springer.com/article/10.100…

🔥PPG Global has just been published in Circulation

PPG is a new metric that complements FFR informing about the benefit of PCI in patients with coronary artery disease

ahajournals.org/doi/10.1161/CI…

PCRonline 🫀 CoreAalst TCTMD William Fearon Ziad Ali Javier Escaned jcspratt

Wow. Even in an open label trial, PCI in the “perfect” patient (amenable anatomy + viability) did not result in QOL improvements at one year over simple tablets.

REVIVED continues to shock the cardiology community

Link jacc.org/doi/10.1016/j.…

Anyone doubting that GLP-1 agonists are no longer diabetic drugs and should be used long term should read this prespecified analysis of the Select trial of non diabetic patients with atherosclerosis

nature.com/articles/s4159…

🏆 Mats C. Højbjerg Lassen wins #HeartFailure2024 Congress #YIA !

New data from 7 large-scale trials suggest that #SGLT2i , when used for CV & kidney protection, may meaningfully reduce risk of new-onset diabetes by 26%!

Further supports #SGLT2i as a core component to #CKM health.

En route to Cardio-renal-metabolic UK Manchester summit!

We've another fantastic & wide-ranging agenda covering health inequalities in #CVRM , approaches to #lifestylemedicine & sex & gender in #CVRM care

I'm speaking on #MASLD & also the intersection of sleep & #CVRM

cvrmuk.com/events/35/card…

Summary of STEP #HFpEF #Semaglutide #HFpEF #GLP1RA

How do you treat patients after acute coronary syndrome? Watch Professor Matthew Budoff's presentation from the 20th #PCSK9 Closed Scientific Expert Meeting >> pcsk9forum.org/post-acs-thera…
#ACS #plaquestabilisation #fibrouscapthickness #heartdisease #atherosclerosis Matthew Budoff MD

Thanks to hours of work by independent angio and viability core labs, a carefully designed analysis plan and our dedicated team, we now have answers to many remaining questions about REVIVED! Join us at #EuroPCR and/or read the paper in #JACC on Wednesday 15th May.

Do you test Lp(a) alongside other lipids? A recommendation in Canadian dyslipidaemia guidelines is driving testing. Read what’s happening in Journals Update on Lpa Forum >> lpaforum.org/canadian-guide…
#Lpa #Lpa testing #heartdisease #dyslipidaemia guidelines #dyslipidaemia #lipids

Don't delay initiation of Heart Failure therapy, prescribe as many as possible, as early as possible. Benefits are seen within days / weeks. Think about the risks of omitting HF therapy!

#HeartFailure2024

Great presentation from Lisa Anderson. Elevated NT-ProBNP levels are associated with increased mortality before an echocardiogram is performed calling for an immediate action even before the LVEF is assessed